Assess whether working capital should be a walk-away (37b48e)

SITUATION IP diligence counsel's financial counterpart is responsible for working capital should be in a public acquirer facing HSR and sector regulators, using regulatory-approval critical-path calendar as the only working extract. A CIM that omitted a material litigation is what reset the timeline for this M&A Due Diligence Legal, IP, and Regulatory file.

DECISION IP diligence counsel's financial counterpart in a public acquirer facing HSR and sector regulators must choose Proceed / Reprice / Walk / Hold using regulatory-approval critical-path calendar after a CIM that omitted a material litigation.

HYPOTHESES TO TEST 1. A CIM that omitted a material litigation is noise around an already-controlled Legal, IP, and Regulatory process in a public acquirer facing HSR and sector regulators, given regulatory-approval critical-path calendar. 2. A CIM that omitted a material litigation is the event in regulatory-approval critical-path calendar that forces Proceed for IP diligence counsel's financial counterpart under M&A Due Diligence. 3. Regulatory-approval critical-path calendar shows a one-file miss after a CIM that omitted a material litigation, not a Legal, IP, and Regulatory program failure. 4. Regulatory-approval critical-path calendar cannot decide working capital should be yet after a CIM that omitted a material litigation; hold is the only M&A Due Diligence close a public acquirer facing HSR and sector regulators can defend.

ANALYSIS REQUIRED 1. Tie quality-of-earnings, working-capital, and contingent items in regulatory-approval critical-path calendar to working capital should be. 2. Name the document IP diligence counsel's financial counterpart still needs before signing. 3. Test whether a CIM that omitted a material litigation is a diligence gap, a price chip, or a walk-away. 4. For this M&A Due Diligence Legal, IP, and Regulatory file, read regulatory-approval critical-path calendar against a CIM that omitted a material litigation and write the one fact that would move working capital should be for IP diligence counsel's financial counterpart.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Legal, IP, and Regulatory packet (regulatory-approval critical-path calendar after a CIM that omitted a material litigation). The follow-on Legal, IP, and Regulatory action is what IP diligence counsel's financial counterpart does next: implement the option, assign an owner, and log the missing fact.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on working capital should be, then the evidence in regulatory-approval critical-path calendar, then the action for IP diligence counsel's financial counterpart - Hypothesis scorecard against regulatory-approval critical-path calendar: supported / rejected / untestable - Missing page in regulatory-approval critical-path calendar after a CIM that omitted a material litigation, if any - Regulatory or exam hook Legal, IP, and Regulatory would cite